Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...
Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Calling people obese is medically "flawed" - and the definition should be split into two, a report from global experts says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback